A PARADIGM SHIFT IN THE MANAGEMENT OF PATIENTS WITH SEVERE AORTIC STENOSIS
Transcatheter aortic valve implantation (TAVI) is a minimally invasive, catheter-based procedure to replace the function of the aortic valve.
A LESS INVASIVE TREATMENT OPTION
TAVI may be an excellent option for certain patients because the prevalence of aortic stenosis and co-morbidities increase the risks associated with surgical aortic valve implantation (SAVI).1 Without intervention, the average symptomatic patient life expectancy is 2 to 5 years.2
<h2 class="tta__headline h2" style="font-weight: normal;">SYMPTOMATIC SEVERE AORTIC STENOSIS<br><b>INCIDENCE IN WESTERN EUROPE<sup>3</sup></b></h2><h2 style="font-size: 60px;">~350,000</h2>
Schwartz F, et al. The effect of aortic valve replacement on survival Circulation. 1982:66:1105-1110.
Lester SJ, Heilbron B, Gin K, et al. The natural history and rate of progression of aortic stenosis. Chest 1998; 113:1109-14.
Medtronic data on file.
Disclaimer: This page may include information about products that may not be available in your region or country. Please consult the approved indications for use. Content on specific Medtronic products is not intended for users in markets that do not have authorization for use.